Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
12 respectivamente.
11 2.
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
0,7%, respectivamente).
profilaktiska heparīna lietošana nepalielināja nopietnas asiņošanas risku, salīdzinot ar placebo (attiecīgi 3, 9% pret 5, 2%), arī cns asiņošanas risku (attiecīgi 1, 0% pret 0, 7%).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
respectivamente, siendo:
kur attiecīgi:
Last Update: 2014-11-17
Usage Frequency: 1
Quality:
h/ ml, respectivamente.
h/ ml.
Last Update: 2012-04-11
Usage Frequency: 3
Quality:
1,2%, respectivamente).
placebo rādītāji pētījumā prowess attiecīgi 0, 4% pret 1, 2%).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
respectivamente, siendo σr
attiecīgi, kur σr
Last Update: 2014-11-17
Usage Frequency: 1
Quality:
55,4; 100) respectivamente;
67, 2; 100) un 100% (95% ci: 55, 4; 100) attiecīgi
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
ingemar persson respectivamente.
ingemar persson.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
32 -4,6%, respectivamente).
2, 7% sākumā), izelpas maksimumplūsmas (pefr) pirms pusdienām (24, 5 l/ ml, v. s.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
10 40 mg/ kg respectivamente.
laukums zem laika un koncentrācijas attiecības līknes (auc∞) vidēji ir robežās no 977, 5 līdz 1872, 5 μg• st/ ml (attiecīgi 20 mg/ kg vai 40 mg/ kg devas gadījumā).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
±1,68 mg/ kg, respectivamente.
0, 72 ± 0, 29 mg/ kg un 1, 58 ± 1, 68 mg/ kg.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
9,2% p=0,06, respectivamente.
12. 0% pret 9. 2% p=0. 06.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
5,7%, respectivamente; p=0,0116).
taču profilaktiska heparīna lietošana palielināja nebūtiskas asiņošanas notikumu risku, salīdzinot ar placebo (attiecīgi 8, 7% pret 5, 7%; p=0, 0116).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
12,3 a 34,6 días), respectivamente.
pēc intravenozas 500 un 1000 mg rituksimaba devas ievadīšanas divas reizes ar divu nedēļu starplaiku vidējā maksimālās koncentrācijas vērtība bija 183 - μg/ ml (robežās no 81, 8 līdz 279 μg/ ml) un 370 μg/ ml (no 212 līdz 637 μg/ ml) un vidējais pusperiods bija attiecīgi 17, 9 dienas (robežās no 12, 3 līdz 31, 3 dienas) un 19, 7 dienas (robežās no 12, 3 līdz 34, 6 dienas).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
79,9; 100,0) para vph 18, respectivamente.
79, 9; 100, 0).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
0,74-1,01; p = 0,060), respectivamente.
visā randomizētajā populācijā, veicot atšķirības testu starp xeloda un 5- fu/ lv, dzīvildzei bez slimības pazīmēm un kopējai dzīvildzei konstatēja riska attiecību attiecīgi 0, 88 (95% ti 0, 77 – 1, 01; p = 0, 068) un 0, 86 (95% ti 0, 74 – 1, 01; p = 0, 060).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
1,6% frente a 0,9%, respectivamente).
3, 6% pacientiem ar nesen veiktu operāciju pret 1, 6% pacientiem, kam nesen nav veikta operācija; placebo: attiecīgi 1, 6% pret 0, 9%).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
figuran, respectivamente, en los anexos i y ii.
ir izklāstīti attiecīgi i un ii pielikumā.
Last Update: 2014-10-23
Usage Frequency: 3
Quality:
calvo como ponente y ponente adjunto, respectivamente.
calvo.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
12,5%, respectivamente; ver sección 4.4).
resist pētījumā izsitumu risks aptivus/ ritonavīra un salīdzinājuma grupās bija līdzīgs (16, 3% pret 12, 5%; skatīt apakšpunktu 4. 4).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.